Analysts’ Recommendations for Colgate-Palmolive, Post-Q2 Results
Colgate-Palmolive’s (CL) performance was less than impressive in the first half of this year, and its second-quarter sales and earnings growth decelerated. Analysts expect headwinds to continue to hurt the company’s sales and earnings in the near term, and have maintained mostly neutral recommendations. Following its second-quarter results, Jefferies lowered its target price on CL stock to $60 from $62.